NCT03080857 is a NA clinical trial of Virtual Platform in Atrial Fibrillation, sponsored by Nova Scotia Health Authority.

Who is sponsoring NCT03080857?

NCT03080857 is sponsored by Nova Scotia Health Authority.

What drugs are being tested in NCT03080857?

Interventions in NCT03080857: Virtual Platform, AliveCor Heart Monitor.

What condition does NCT03080857 study?

NCT03080857 studies Atrial Fibrillation.

Is NCT03080857 still recruiting?

NCT03080857 is currently completed. Last updated 22 July 2020.

Last reviewed 2020-07-22 · How we verify

NCT03080857

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Computer Simulated Atrial Fibrillation Tool

Completed NA Last updated 22 July 2020

What this trial tests

NA trial testing Virtual Platform in Atrial Fibrillation in 94 participants. Completed in 31 May 2020.

Timeline

15 May 2018

Primary endpoint
31 December 2019

31 May 2020

Quick facts

Lead sponsor	Nova Scotia Health Authority
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	94
Start date	15 May 2018
Primary completion	31 December 2019
Estimated completion	31 May 2020
Sites	1 location across Canada

Drugs / interventions tested

Virtual Platform
AliveCor Heart Monitor

Conditions studied

Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

Nova Scotia Health Authority — full company profile →

Who can join

18 and older, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This will be a before-after study, using a prospective cohort to evaluate the use of a virtual, patient-centered platform as compared to a historical cohort of patients with atrial fibrillation (AF) and if the education and support provided by the platform will reduce Emergency Department visits for AF.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A virtual platform to deliver ambulatory care for patients with atrial fibrillation.
Weng W, Blanchard C, Reed JL, Matheson K, et al · · 2021 · cited 10× · PMID 35265891 · DOI 10.1016/j.cvdhj.2020.11.005

Verify or expand the search:

Other recruiting trials for Atrial Fibrillation

Currently open trials in the same condition.

NCT07429214 — A Study of VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software in Participants With PAF or PsAF · NA · recruiting
NCT07271238 — Feasibility Study on the VERAFEYE Imaging and Navigation System for Guided Catheter Ablation Procedures · NA · recruiting
NCT07388108 — Atrial Dyssynchrony to Predict Arrhythmias in the Postoperative Setting of Cardiovascular Surgery. · recruiting
NCT07428967 — AV Node Ablation and CONDUCTion System Pacing for Atrial Fibrillation With Preserved Left Ventricular Function · NA · recruiting
NCT06650995 — AlEX-DHF: Ablation and Exercise in Diastolic Heart Failure · NA · recruiting

Other Nova Scotia Health Authority trials

Trials by the same sponsor.

NCT03716999 — Starlight Therapy in Palliative Care · not yet recruiting
NCT06987409 — Continuous Erector Spinae Block for Analgesia Following Lumbar Decompression · NA · not yet recruiting
NCT06575621 — Knee-hip Surgery Wait-list Support Program · NA · not yet recruiting
NCT07143162 — YOGA-FIT: Protocol for a Crossover Trial Investigating the Feasibility and Impact of Yoga for People With Stroke · NA · not yet recruiting
NCT07239999 — Comparing Spinal Anesthesia With 1% Chloroprocaine Versus 1% Mepivacaine in Patients Undergoing Outpatient Primary Total · Phase 4 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03080857 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nova Scotia Health Authority
Last refreshed: 22 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03080857.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing